AGIO

AGIOS PHARMACEUTICALS, INC.

SEC CIK 1439222
$33.08 +22.8% · 90 days
90-day buys
$0
0 open-market
90-day sells
$1.2M
7 open-market
Net insider flow
−$1.2M
Net selling
Filings shown
140
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at AGIO have sold a net $1.2M of stock (0 open-market buys vs 7 sells).

Largest recent trade: Burns James William sold $697.4K of AGIO, trimming their stake 36%.

Most active filer: Gheuens Sarah, with 27 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for AGIO, newest first
View on SEC EDGAR ↗
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jan 9, 2024 ΔOwn −6.0%

Gheuens Sarah sold $41.1K of AGIO, trimming their stake 6%.

−$41.1K
1,789 sh @ $23
AGIO
Sell Milanova Tsveta · Chief Commercial Officer · Open-market sale · filed Jan 5, 2024 ΔOwn −24%

Milanova Tsveta sold $64.8K of AGIO, trimming their stake 24%.

−$64.8K
2,902 sh @ $22
AGIO
Sell Jones Cecilia · Chief Financial Officer · Open-market sale · filed Sep 28, 2023 ΔOwn −19%

Jones Cecilia sold $54K of AGIO, trimming their stake 19%.

−$54K
2,179 sh @ $25
AGIO
Sell Burns James William · Chief Legal Officer · Open-market sale · filed Aug 21, 2023 ΔOwn −21%

Burns James William sold $168.1K of AGIO, trimming their stake 21%.

−$168.1K
6,395 sh @ $26
Advertisement
AGIO
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Aug 10, 2023 ΔOwn −28%

Goff Brian sold $259.3K of AGIO, trimming their stake 28%.

−$259.3K
10,178 sh @ $25
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jun 30, 2023 ΔOwn −6.6%

Gheuens Sarah sold $48.4K of AGIO, trimming their stake 7%.

−$48.4K
1,707 sh @ $28
AGIO
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Jun 30, 2023 ΔOwn −45%

Goff Brian sold $324.7K of AGIO, trimming their stake 45%.

−$324.7K
11,449 sh @ $28
AGIO
Sell Jones Cecilia · Chief Financial Officer · Open-market sale · filed Jun 30, 2023 ΔOwn −30%

Jones Cecilia sold $45.3K of AGIO, trimming their stake 30%.

−$45.3K
1,597 sh @ $28
AGIO
Sell Milanova Tsveta · Chief Commercial Officer · Open-market sale · filed Jun 30, 2023 ΔOwn −30%

Milanova Tsveta sold $45.9K of AGIO, trimming their stake 30%.

−$45.9K
1,618 sh @ $28
AGIO
Buy Scadden David · Director · Open-market purchase · filed Mar 20, 2018 ΔOwn +54%

Scadden David, AGIO's Director, spent $16.7K of their own money on 200 shares at $83, growing their stake 54%.

+$16.7K
200 sh @ $83
Advertisement

About AGIO insider activity

This page tracks every recent Form 4 filed for AGIOS PHARMACEUTICALS, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is AGIO insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for AGIOS PHARMACEUTICALS, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.